Unknown PHASE3 INTERVENTIONAL 2-arm NCT01053182

Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches

A Phase Ⅲ Study of Respiratory Complications Associated With Esophagectomy Through Either Ivor-Lewis or Sweet Approach for the Treatment of Middle or Lower Third Intrathoracic Esophageal Carcinoma

Sponsor: Sichuan University

Conditions Diaphragm Esophageal Cancer Postoperative Complications Pulmonary Function

Interventions Ivor-Lewis Esophagectomy Sweet Esophagectomy

Updated 4 times since 2017 Last updated: Jan 20, 2010 Started: Jan 31, 2010 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01053182, this PHASE3 trial focuses on Diaphragm and Esophageal Cancer and remains ongoing. Sponsored by Sichuan University, it has been updated 4 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sichuan University

Data source: Sichuan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China